•  
  •  
 

Abstract

Aging is characterized by a progressive decline in cellular function, regenerative capacity, and metabolic efficiency, leading to tissue dysfunction and age-related diseases. Pharmacological interventions targeting cellular resilience pathways represent a promising approach for delaying or reversing age-associated decline. The small molecule RT175, a non-immunosuppressive immunophilin ligand, has shown potential in enhancing mitochondrial function to promote healthy aging. Using a melanoblast cell line, our results showed that RT175 induced cell growth inhibition, enhanced pigmentation, altered mitochondrial gene expression, increased mitochondrial DNA content, and inhibit GSK3β. RT175 also promoted in vivo tissue regeneration, suggesting that RT175 exerts pro-regenerative effects by regulating gene expression program governing mitochondrial metabolism, melanogenesis, and cellular plasticity. These findings highlight RT175 as a potential therapeutic for aging-related decline.

Included in

Life Sciences Commons

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.